Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria

Sponsor
University Hospital Muenster (Other)
Overall Status
Completed
CT.gov ID
NCT00385372
Collaborator
(none)
150
1
26.9
5.6

Study Details

Study Description

Brief Summary

Patients with chronic urticaria undertake a five week elimination diet (pseudoallergen free diet). The efficacy of the diet will be determined by symptom score, by the use of rescue medication (oral antihistamines and glucocorticosteroids) and by a Quality of Life Questionnaire on week 0 and week 5. All patients with sufficient response (regarding the urticaria score) enter a second dietary part over six weeks, whereas a provocation diet is carried out. Each diet week a choice of pseudoallergen rich food is added, sorted by the type of pseudoallergens (e.g. biogenic amines, organic acids, flavours, additives). This study is conducted to investigate if the provocation diet could be a new diagnostic intervention to elucidate clinical relevant pseudoallergens.

Condition or Disease Intervention/Treatment Phase
  • Procedure: elimination diet
  • Procedure: provocation diet
N/A

Detailed Description

Chronic urticaria is defined as a daily or almost daily spontaneous occurrence of wheals that cause itching and lasting for at least six weeks. If there is no indication of a possible eliciting agent and because approximately 70% of patients benefit from it, a low-pseudoallergen diet should be carried out for 5 weeks. Although the low-pseudoallergen diet is successful, no explanation of the underlying mechanisms exists. On DBPC oral provocation testing with known food additives, only a small amount of patients, who experienced remission after a low-pseudoallergen diet react with new wheals and/or angioedema. For this discrepancy, natural food ingredients and new food additives are included in the dietary diagnostic. The high amount of substances, which are administrated within oral provocation testing can not reflect a realistic diet situation. Often it is impossible to ingest corresponding amounts of foods to reach the same concentration such as the provocation amount. Recording change reactions between food ingredients and the individual metabolism of the patients, the "step by step" food provocation method reveals itself to be most effective. In addition, individual predilections, amounts and frequency of ingested foods, are taken into consideration.

Study Design

Study Type:
Interventional
Official Title:
Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria
Study Start Date :
Jan 1, 2005
Actual Primary Completion Date :
Jan 1, 2007
Actual Study Completion Date :
Apr 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • signed informed consent

    • chronic urticaria (duration: at least 6 weeks)

    • patients who suffered from urticaria and/or angio oedema at least once a week for a duration of at least 4 weeks)

    • Males and females, age between 7 and 80 years

    • inpatients and outpatients

    • oral antihistamines and glucocorticosteroids are allowed as concomitant medication (if needed)

    Exclusion Criteria:
    • pregnant or breastfeeding woman

    • patients suffering from diabetes mellitus

    • patients with cachexia

    • known food allergies of food which will be administrated within the elimination diet (e.g. milk, cereals)

    • isolated urticaria with known aetiology (e.g. physical urticaria, aquagene urticaria, urticaria factitia, cholinergic urticaria), Urticaria pigmentosa mastocytoses)

    • patients, seemed to be uncompliant under suspicion of the investigator

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Clinics of Münster, Department of Dermatology Münster Germany 48149

    Sponsors and Collaborators

    • University Hospital Muenster

    Investigators

    • Principal Investigator: Randolf Brehler, senior MD, University Hospital Münster, Department of Dermatology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00385372
    Other Study ID Numbers:
    • BBU_PAD_CU_1
    First Posted:
    Oct 9, 2006
    Last Update Posted:
    Jan 29, 2009
    Last Verified:
    Feb 1, 2007

    Study Results

    No Results Posted as of Jan 29, 2009